These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3325716)

  • 1. Enhancement of the delayed-type hypersensitivity reaction by oxazaphosphorines.
    Turk JL
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):605-10. PubMed ID: 3325716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of delayed hypersensitivity to tuberculin by antigenic competition. A positive immunoregulatory mechanism sensitive to cyclophosphamide.
    Dwyer JM; Parker D; Turk JL
    Immunology; 1981 Apr; 42(4):549-59. PubMed ID: 6453829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparability of delayed hypersensitivity in various rodents. II. Jones-Mote type hypersensitivity in guinea-pigs immunized with sheep erythrocytes and its modification by cyclophosphamide or BCG pre-treatment.
    Nomoto K; Yoshida S; Himeno K
    Immunology; 1980 Sep; 41(1):83-90. PubMed ID: 7429556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among differentiated T-cell subpopulations. I. Dissociated development of tuberculin type hypersensitivity, Jones-Mote type hypersensitivity and activation of helper function.
    Ohmichi Y; Nomoto K; Yamada H; Takeya K
    Immunology; 1976 Jul; 31(1):101-10. PubMed ID: 800398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D
    Immunol Rev; 1982; 65():99-113. PubMed ID: 6214496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between B-cell stimulation and delayed hypersensitivity. The effect of cyclophosphamide pretreatment on antibody production.
    Noble B; Parker D; Scheper RJ; Turk JL
    Immunology; 1977 Jun; 32(6):885-91. PubMed ID: 142067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of immune suppressor mechanisms in humans by oxazaphosphorines.
    Berd D; Mastrangelo MJ
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):569-77. PubMed ID: 2963936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
    Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
    J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of contact sensitivity and antigenic competition by the intravenous administration of contact sensitizers.
    Nakano Y; Nakano K
    Immunology; 1981 Jan; 42(1):111-8. PubMed ID: 7461721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
    Boerrigter GH; Scheper RJ
    Clin Exp Immunol; 1984 Oct; 58(1):161-6. PubMed ID: 6478648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
    Gauthier-Rahman S
    Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation of immune depression and B-cell stimulation during the development of delayed hypersensitivity to soluble antigens.
    Scheper RJ; Parker D; Noble B; Turk JL
    Immunology; 1977 Feb; 32(2):265-72. PubMed ID: 300357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophils in tuberculin and "Jones-Mote" delayed reactions of humans.
    Askenase PW; Atwood JE
    J Clin Invest; 1976 Nov; 58(5):1145-54. PubMed ID: 791969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.
    Sewell WA; de Moerloose PA; Hamilton JA; Schrader JW; Mackay IR; Vadas MA
    Immunology; 1987 Aug; 61(4):483-8. PubMed ID: 3127325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.
    Bovbjerg DH; Ader R; Cohen N
    Clin Exp Immunol; 1986 Dec; 66(3):539-50. PubMed ID: 2436841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclophosphamide on the expression and induction of delayed hypersensitivity.
    Himeno K; Nomoto K; Takeya K
    Microbiol Immunol; 1978; 22(11):719-30. PubMed ID: 85240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D; Cameron AE
    Int J Tissue React; 1984; 6(3):205-11. PubMed ID: 6480267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of thymectomy on induction of immunologic tolerance in the effectors of delayed hypersensitivity].
    Chernousov AD; Fontalin LN; Akopian NG; Kondrat'eva IA
    Biull Eksp Biol Med; 1979 Oct; 88(10):434-7. PubMed ID: 315242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of contact sensitivity.
    Polak L
    Monogr Allergy; 1980; 15():1-170. PubMed ID: 6444240
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of cyclophosphamide and role suppressor cells in the desensitization of delayed hypersensitivity.
    Parker D; Dwyer JM; Turk JL
    Immunology; 1981 May; 43(1):191-6. PubMed ID: 6166543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.